FT Fresh Tracks Therapeutics, Inc. Stock: price and insider trades · United States · SEC (Form 4)Source id SEC:fresh-tracks-therapeutics-inc-59ba75 US · SEC (Form 4) Mcap US$2.2B Track the Fresh Tracks Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 11 June 2024 (Acquisition). Among the most active insiders: Exploration Capital, LLC. The full history is openly available.
€709,911
19 ops.
Buy Volume
Analyst consensus: bullish or bearish? Analysts rate Fresh Tracks Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 June 2024
All Executives24 Thresholds0 Prospectus0 Other0
Declarations 24 total
319,315 shares @ US$0.94 39.1% of flow Common Stock SEC:0001213900-24-051866:0
Canonical exit: 5 Sept 2024 (T+90) 80 shares @ US$0.87 0.0% of flow Common Stock SEC:0001213900-24-048558:0
Canonical exit: 27 Aug 2024 (T+90) 6,879 shares @ US$0.91 0.8% of flow Common Stock SEC:0001213900-24-046344:0
Canonical exit: 19 Aug 2024 (T+90) 73,768 shares @ US$0.92 8.9% of flow Common Stock SEC:0001213900-24-045315:0
Canonical exit: 14 Aug 2024 (T+90) 320 shares @ US$0.89 0.0% of flow Common Stock SEC:0001213900-24-040869:0
Canonical exit: 4 Aug 2024 (T+90) 162,351 shares @ US$0.92 19.8% of flow Common Stock SEC:0001213900-24-039764:0
Canonical exit: 30 Jul 2024 (T+90) 4,277 shares @ US$0.91 0.5% of flow Common Stock SEC:0001213900-24-035431:0
Canonical exit: 18 Jul 2024 (T+90) 2,188 shares @ US$0.88 0.3% of flow Common Stock SEC:0001213900-24-032240:0
Canonical exit: 8 Jul 2024 (T+90) 12,928 shares @ US$0.91 1.5% of flow Common Stock SEC:0001213900-24-030877:0
Canonical exit: 2 Jul 2024 (T+90) 51,634 shares @ US$0.90 6.1% of flow Common Stock SEC:0001213900-24-028916:0
Canonical exit: 25 Jun 2024 (T+90) 10 shares @ US$0.90 0.0% of flow Common Stock SEC:0001213900-24-024839:0
Canonical exit: 17 Jun 2024 (T+90) 5,703 shares @ US$0.91 0.7% of flow Common Stock SEC:0001213900-24-022246:0
Canonical exit: 9 Jun 2024 (T+90) 20,109 shares @ US$0.90 2.4% of flow Common Stock SEC:0001213900-24-018112:0
Canonical exit: 26 May 2024 (T+90) 49,951 shares @ US$0.88 5.8% of flow Common Stock SEC:0001213900-24-016223:0
Canonical exit: 20 May 2024 (T+90) 10,958 shares @ US$0.98 1.4% of flow Common Stock SEC:0001213900-24-004190:0
Canonical exit: 11 Apr 2024 (T+90) 38,017 shares @ US$0.98 4.8% of flow Common Stock SEC:0001213900-24-003009:0
Canonical exit: 8 Apr 2024 (T+90) 23,877 shares @ US$0.89 2.8% of flow Common Stock SEC:0001213900-24-001658:0
Canonical exit: 2 Apr 2024 (T+90) 47,000 shares @ US$0.84 5.1% of flow Common Stock SEC:0001213900-23-097429:0
Canonical exit: 19 Mar 2024 (T+90) ▼ VP of Finance & CAO · Executives · 8 Dec 2023
74 shares @ US$0.91 100.0% of flow Common Stock SEC:0001628280-23-041229:0
◇ Former Chief R&D Officer & COO · Executives · 1 Sept 2023
35,000 shares Common Stock SEC:0001628280-23-041230:0
7,579 shares @ US$0.85 100.0% of flow Common Stock SEC:0001213900-23-093858:0
Canonical exit: 3 Mar 2024 (T+90) ▼ VP of Finance & CAO · Executives · 4 Dec 2023
36.44 shares @ US$0.8501 100.0% of flow Common Stock SEC:0001628280-23-040639:0
◇ President and CEO · Executives · 2 Oct 2023
55,000 shares Common Stock SEC:0001628280-23-033916:0
◇ Gen Counsel, CCO, & Secretary · Executives · 2 Oct 2023
20,000 shares Common Stock SEC:0001628280-23-033914:0
About Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc. is a company focused on developing innovative treatments for psychiatric disorders. It is listed on the XNAS market.